(VSAR) - Earnings & Price History

VSAR: - 19.5, $693.77M, 1.95 (11.11%)

Sector: Healthcare - Industry: Drugs - Generic

Versartis, Inc. operates as an endocrine-focused biopharmaceutical company in the United States. The company is developing VRS-317, a long-acting recombinant human growth hormone, which is in Phase 3 clinical trials for the treatment of growth hormone deficiency. It develops drug candidates that it has licensed from Amunix Operating, Inc. The company was founded in 2008 and is headquartered in Menlo Park, California.Key Statistics

Past VSAR reports
Earning DateTimeTitleEPS-e EPS-a ClosePrev CloseOpen Day LowDay High Gap % CFO %Change % Volume
2017-02-21AMC-0.6219.518.9519.5518.3519.883.17%-0.26%2.90%501.09K
2017-02-17AMC-0.62
2017-02-16AMC-0.6216.3515.715.715.5516.454.14%4.14%89.42K
2016-10-28AMC-0.26
2016-10-27AMC-0.2612.2511.8511.9511.812.30.84%2.51%3.38%342.00K
2016-02-12AMC-0.71
2016-02-11AMC-0.718.187.978.287.878.433.89%-1.21%2.63%186.39K
2016-02-10AMC-0.717.978.658.477.768.65-2.08%-5.90%-7.86%284.64K
2015-08-04BMO-0.6418.6818.118.0417.4819.24-0.33%▲3.55%3.20%186.24K
2015-08-03AMC-0.6418.6818.118.0417.4819.24-0.33%▲3.55%3.20%186.24K
2015-05-06AMC-0.6315.4617.2915.41516.46-10.93%0.39%-10.58%1.03M
2015-05-05AMC-0.6317.2917.2217.3116.8917.530.52%-0.12%0.41%43.61K
2015-05-04AMC-0.6317.2217.3117.3116.8717.76-0.52%-0.52%85.11K
2014-11-06AMCVersartis Inc-0.5719.4819.341817.5719.77-6.93%8.22%0.72%42.10K

Login | Register
Thursday Aug 24, 2017   EST
Enter a Ticker:

Economic Calendar

MBA Mortgage Applications 7:00 AM ET PMI Composite Flash 9:45 AM ET New Home Sales 10:00 AM ET EIA Petroleum Status Report 10:30 AM ET 2-Yr FRN Note Auction 11:30 AM ET Robert Kaplan Speaks 1:05 PM ET  

AAII Sentiment Survey

BULL^ neut ^ BEAR

Chart

index chart
index color
SPY244.56-0.88-0.36%49,996,850

Upgrades/Downgrades